Q32 Bio Inc.
QTTB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661998
In the last 90 days, Q32 Bio Inc. insiders filed 0 open-market purchases and 3 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $282.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Q32 Bio Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −1 vs. Q3 2025
- Shares held
- 8.04M
- −384.9K (−4.6%) vs. Q3 2025
- Total value
- $26.7M
- +$10.0M (+60.3%) vs. Q3 2025
- New holders
- 7
- 9 more added
- Sold out
- 8
- 20 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QTTB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $282.6M |
| Q1 2026 | 54 | $60.6M |
| Q4 2025 | 52 | $26.7M |
| Q3 2025 | 53 | $16.6M |
| Q2 2025 | 61 | $13.4M |
| Q1 2025 | 73 | $15.5M |
| Q4 2024 | 92 | $37.8M |
| Q3 2024 | 73 | $405.8M |
| Q2 2024 | 54 | $144.2M |
| Q1 2024 | 39 | $125.9M |
| Q4 2023 | 58 | $11.4M |
| Q3 2023 | 58 | $20.8M |
| Q2 2023 | 59 | $15.9M |
| Q1 2023 | 62 | $20.0M |
| Q4 2022 | 79 | $27.3M |
| Q3 2022 | 83 | $38.7M |
| Q2 2022 | 87 | $49.9M |
| Q1 2022 | 107 | $89.7M |
| Q4 2021 | 121 | $123.0M |
| Q3 2021 | 119 | $252.1M |
| Q2 2021 | 118 | $239.9M |
| Q1 2021 | 109 | $272.7M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Q32 Bio Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 54 | $0 | 0.00% | −165−75.3% | Reduced |
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 2 | $7 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 11 | $37 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 19 | $63 | 0.00% | −803−97.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 30 | $100 | 0.00% | +30 | New |
| Group One Trading, L.P. | 34 | $113 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 70 | $231 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 98 | $326 | 0.00% | −512−83.9% | Reduced |
| Advisor Group Holdings, Inc. | 132 | $437 | 0.00% | −55−29.4% | Reduced |
| SBI Securities Co., Ltd. | 157 | $521 | 0.00% | −7,999−98.1% | Reduced |
| Nisa Investment Advisors, LLC | 166 | $551 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 235 | $1.00K | 0.00% | −818−77.7% | Reduced |
| BNP Paribas Arbitrage, SA | 308 | $1.02K | 0.00% | −124−28.7% | Reduced |
| JPMorgan Chase & Co | 324 | $1.08K | 0.00% | +320+8,000.0% | Added |
| Russell Investments Group, Ltd. | 454 | $1.51K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 500 | $1.66K | 0.00% | +500 | New |
| Rockefeller Capital Management L.P. | 577 | $1.92K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 976 | $3.24K | 0.00% | −5,506−84.9% | Reduced |
| Bank of America Corp | 1,035 | $3.44K | 0.00% | −490−32.1% | Reduced |
| SRS Capital Advisors, Inc. | 1,111 | $3.69K | 0.00% | −104−8.6% | Reduced |
| Global Retirement Partners, LLC | 1,500 | $4.98K | 0.00% | −3,500−70.0% | Reduced |
| Federated Hermes, Inc. | 2,273 | $7.55K | 0.00% | −101−4.3% | Reduced |
| FMR LLC | 3,364 | $11.2K | 0.00% | −12,503−78.8% | Reduced |
| EverSource Wealth Advisors, LLC | 4,640 | $15.4K | 0.00% | −385−7.7% | Reduced |
| Morgan Stanley | 5,478 | $18.2K | 0.00% | −5,865−51.7% | Reduced |
| UBS Group AG | 13,606 | $45.2K | 0.00% | +8,360+159.4% | Added |
| Scientech Research LLC | 15,510 | $51.5K | 0.03% | +15,510 | New |
| ADAR1 Capital Management, LLC | 20,000 | $66.4K | 0.00% | +20,000 | New |
| XTX Topco Ltd | 20,353 | $67.6K | 0.00% | +20,353 | New |
| State Street Corp | 21,237 | $70.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 24,698 | $81.0K | 0.00% | +9,862+66.5% | Added |
| Northern Trust Corp | 25,033 | $83.1K | 0.00% | −6,920−21.7% | Reduced |
| Jane Street Group, LLC | 25,374 | $84.2K | 0.00% | +25,374 | New |
| Affinity Asset Advisors, LLC | 27,777 | $92.2K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 45,728 | $151.8K | 0.00% | +35,611+352.0% | Added |
| Two Sigma Investments, LP | 46,825 | $155.5K | 0.00% | +15,319+48.6% | Added |
| Acadian Asset Management LLC | 48,373 | $159.0K | 0.00% | +18,634+62.7% | Added |
| Monaco Asset Management SAM | 50,919 | $169.1K | 0.05% | −260,218−83.6% | Reduced |
| Millennium Management LLC | 51,268 | $170.2K | 0.00% | −53,504−51.1% | Reduced |
| BlackRock, Inc. | 59,932 | $199.0K | 0.00% | −33,073−35.6% | Reduced |
| Renaissance Technologies LLC | 99,600 | $330.7K | 0.00% | +52,300+110.6% | Added |
| Geode Capital Management, LLC | 106,113 | $352.4K | 0.00% | +17,617+19.9% | Added |
| Opaleye Management Inc. | 213,363 | $708.4K | 0.09% | +213,363 | New |
| Sanofi | 244,083 | $810.4K | 0.26% | 00.0% | Unchanged |
| Pfizer Inc | 277,777 | $922.2K | 0.39% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 320,482 | $1.06M | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 321,051 | $1.07M | 0.00% | +25,642+8.7% | Added |
| Acorn Capital Advisors, LLC | 493,425 | $1.64M | 0.56% | −310,000−38.6% | Reduced |
| Carlyle Group Inc. | 1,102,741 | $3.62M | 0.03% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,092,106 | $6.95M | 0.80% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,252,987 | $7.48M | 0.15% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −133,903−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,749−100.0% | Sold out |
| DLK Investment Management, LLC | 0 | $0 | 0.00% | −10,333−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −2,138−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −472−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −227−100.0% | Sold out |
| St Germain D J Co Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |